| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007032445A1 Protein kinase inhibitors |
| 03/22/2007 | WO2007032255A1 T-cell receptor and nucleic acid encoding the receptor |
| 03/22/2007 | WO2007031853A2 Therapeutic combination of hamlet and a hdac inhibitor to treat cancer |
| 03/22/2007 | WO2007031745A1 Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity |
| 03/22/2007 | WO2007031726A1 Purine derivatives having immuno-modulating properties |
| 03/22/2007 | WO2007031574A2 Therapeutic use of outer shigella protein f (os pf) |
| 03/22/2007 | WO2007031428A1 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 03/22/2007 | WO2007031030A1 Drug for treating tumor and use thereof in the manufature of medicaments for treating tumor |
| 03/22/2007 | WO2007030992A1 Medicament for the treatment of tumors and its use for manufacturing a medicament for the treatment of tumors |
| 03/22/2007 | WO2007030930A1 Methods and compositions for modulating tumor cell activity |
| 03/22/2007 | WO2007014455A9 Cancerous disease modifying antibodies |
| 03/22/2007 | WO2007008780A3 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 03/22/2007 | WO2007001851A3 Compositions and methods for the diagnosis and treatment of tumor |
| 03/22/2007 | WO2006127321A3 Formulations of suberoylanilide hydroxamic acid and methods for producing same |
| 03/22/2007 | WO2006122914A3 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous |
| 03/22/2007 | WO2006116631A3 Cancer specific pcna isoform binding antibodies and uses thereof |
| 03/22/2007 | WO2006116592A9 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 03/22/2007 | WO2006099141A3 Anti-mesothelin antibodies |
| 03/22/2007 | WO2006098961A3 Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity |
| 03/22/2007 | WO2006081994A3 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma |
| 03/22/2007 | WO2006078574A3 Mitotic kinesin inhibitors |
| 03/22/2007 | WO2006076414A3 Identification of phospholipase a2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action |
| 03/22/2007 | WO2006068742A3 Use of cathepsin inhibitors for reversing or preventing resistance of a cancer cell to a cytotoxic agent |
| 03/22/2007 | WO2006030217A3 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| 03/22/2007 | WO2005120493A8 Anticancer effect enhancer |
| 03/22/2007 | WO2005115470A3 PHARMACEUTICAL COMPOSITIONS COMPRISING β-CARBOLINE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER |
| 03/22/2007 | WO2005092377A9 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 03/22/2007 | WO2002011563A8 Food supplement |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
| 03/22/2007 | US20070066837 Podophyllotoxin derivatives as antitumor agents |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066681 Pharmaceutical composition for treating fatty liver or hepatic disease |
| 03/22/2007 | US20070066651 Pyrazoline derivatives useful for the treatment of cancer |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 03/22/2007 | US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide |
| 03/22/2007 | US20070066564 Sulfotransferase inhibitor |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066542 Novel imidazole derivatives, their preparation and their use as medicaments |
| 03/22/2007 | US20070066536 Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070066515 Novel glycoprotein and pharmaceutical composition containing the same |
| 03/22/2007 | US20070066513 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization |
| 03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 03/22/2007 | US20070065921 Methods and products related to producing low molecular weight heparin |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065485 Therapeutic delivery of carbon monoxide |
| 03/22/2007 | US20070065446 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | US20070065380 provitamin C is prepared from Lycium fruit extract; decomposed in the body to produce vitamin C; improved stability in the body and prolonged life in the body; bioavailability; vitamin C-fortified food; apply to skin protecting from ultraviolet damage, wrinkles and aging |
| 03/22/2007 | US20070065362 Gastrin receptor-avid peptide conjugates |
| 03/22/2007 | DE102005044102A1 Composition for treating malignant myeloma or other CD138-positive tumors, comprises a ULBP2-antiCD138 protein for stimulating an immune response through the NKG2D receptor |
| 03/22/2007 | CA2845251A1 Compositions for the therapy of bcl2-associated cancers and methods of preparation thereof |
| 03/22/2007 | CA2820201A1 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/22/2007 | CA2622725A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | CA2622614A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622575A1 Prok2 antagonists and methods of use |
| 03/22/2007 | CA2621983A1 Azafused cyclin dependent kinase inhibitors |
| 03/22/2007 | CA2621939A1 Therapeutic use of outer shigella protein f (os pf) |
| 03/22/2007 | CA2621830A1 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 03/22/2007 | CA2621363A1 Methods and compositions for modulating tumor cell activity |
| 03/22/2007 | CA2619298A1 Modified antigen binding molecules with altered cell signaling activity |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1764368A1 Antimitotic halogenated derivatives of Vinca alkaloids |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764113A1 Antibodies against lung cancer, antigens and methods of use thereof for treating lung cancer |
| 03/21/2007 | EP1764075A1 Tissue factor production inhibitor |
| 03/21/2007 | EP1763526A1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 03/21/2007 | EP1763523A1 Quinazolinedione derivatives as parp inhibitors |
| 03/21/2007 | EP1763514A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 03/21/2007 | EP1763509A1 Alpha-helical mimetics |
| 03/21/2007 | EP1763507A2 Alpha-amino acid derivates with antiinflammatory activity |
| 03/21/2007 | EP1763500A1 Novel angiogenesis inhibitors and pharmaceutical and cosmetic use thereof |
| 03/21/2007 | EP1763372A2 Radionuclides for medical use |
| 03/21/2007 | EP1763367A2 Improved adjuvant therapy of g250-expressing tumors |
| 03/21/2007 | EP1763365A2 Antibodies for selective apoptosis of cells |
| 03/21/2007 | EP1763356A2 Composition comprising a survivin antisense oligonucleotide and gemcitabine for the treatment of cancer |
| 03/21/2007 | EP1763352A1 Combination product comprising src kinase inhibitor azd0530 and an antioestrogen or egfr-tk-inhibitor |
| 03/21/2007 | EP1763345A2 Kinase inhibitors for treating cancers |
| 03/21/2007 | EP1678189B1 Process for the preparation of trans- or cis-diammoniumdichlorodihydroxyplatinum(iv) salts and derivatives and their use for the preparation of pharmaceutical active agents |
| 03/21/2007 | EP1551409B1 Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of cancer |
| 03/21/2007 | EP1461359B1 Novel anti-igf-ir antibodies and uses thereof |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1339735B1 Method for preparing tryptophan rich peptides |
| 03/21/2007 | EP1339415B1 composition of multipurpose high functional alkaline solution composition, preparation thereof, and use as nonspecific immunostimulator |
| 03/21/2007 | EP1337850B1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP1126876B1 Adjuvant systems and vaccines |
| 03/21/2007 | EP1038025B1 Genetic alterations associated with cancer |
| 03/21/2007 | EP0902839B1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 03/21/2007 | CN1934256A Decoy nucleic acid to synoviolin gene promoter |
| 03/21/2007 | CN1934247A Cancerous disease modifying antibodies |